HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional)
ID: RFA-DA-19-019 • Type: Posted
Opportunity Assistant
Loading
Overview
Category of Funding
Education
Health
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 12/10/18 the National Institutes of Health posted grant opportunity RFA-DA-19-019 for HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional) with funding of $7.0 million.
The grant will be issued under grant program 93.279 Drug Abuse and Addiction Research Programs.
Timing
Posted Date
Dec. 10, 2018, 12:00 a.m. EST
Closing Date
Sept. 8, 2021, 12:00 a.m. EDT Past Due
Last Updated
Dec. 10, 2018, 11:52 a.m. EST
Version
1
Archive Date
Oct. 14, 2021
Eligibility
Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Award Sizing
Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$7,000,000
Estimated Number of Grants
Not Listed
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 496-3405
Additional Information Site